JZJianping Zhang

Jianping Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jianping Zhang has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Jian Shen

    Nanjing Medical University

    4 shared publications
  • Fei Jiang

    Department of Nutrition and Food Hygiene, School of Public Health, Nanjing Medical University, China

    3 shared publications
  • Guoguang Wang

    Department of General Surgery, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China

    3 shared publications
  • Ming Lu

    Nanjing Medical University

    3 shared publications
  • Qinqiang Liu

    Department of General Surgery, The Second Affiliated Hospital, Nanjing Medical University, China

    3 shared publications
  • Zhong Li

    Department of Nutrition and Food Hygiene, School of Public Health, Nanjing Medical University, China

    3 shared publications

Latest Publications

  • Open Access

    Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia

    by Dejian Yuan, Tizhen Yan, Shiqiang Luo, Jun Huang, Jianqiang Tan, Jianping Zhang, Victor Wei Zhang, Yueyuan Lan, Taobo Hu, Jing Guo, et al.

    ARR3has been associated with X-linked, female-limited, high myopia. However, using exome sequencing (ES), we identified the first high myopia case with hemizygousARR3-related mutation in a male patient in a Southern Chinese family. This novel truncated mutation (ARR3: c.569C>G, p.S190*) co-segregated with the disease phenotype in affected family members and demonstrated that high myopia caused byARR3is not X-linked, female-limited, where a complicated X-linked inheritance pattern may exist. Thus, our case expanded the variant spectrum inARR3and provided additional information for genetic counseling, prenatal testing, and diagnosis. Moreover, we characterized the nonsense-mediated decay of theARR3mutant mRNA and discussed the possible underlying pathogenic mechanisms.


  • Open Access

    Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and metabolic reprogramming

    by Yi Dai, Fan Li, Yuwen Jiao, Guoguang Wang, Tian Zhan, Yunwei Xia, Hanyang Liu, Haojun Yang, Jianping Zhang, Liming Tang

    Platinum drug treatment is one of the most predominant chemotherapeutic strategies for patients with gastric cancer (GC). However, the therapeutic effect is less than satisfactory, largely due to the acquired resistance to platinum drugs. Therefore, a better understanding of the underlying mechanisms can greatly improve the therapeutic efficacy of GC. In this study, we aimed to investigate the chemo-resistance related functions/mechanisms and clinical significance of glucose-regulated protein 75 (GRP75) in GC. Here, our data showed that compared with SGC7901 cells, the expression of GRP75 was markedly higher in cisplatin-resistance cells (SGC7901CR). Knockdown of GRP75 abolished the maintenance of mitochondrial membrane potential (MMP) and inhibited the nuclear factor erythroid-2-related factor 2 (NRF2), phosphatidylinositol 3 kinase/protein kinase B (PI3K/AKT), hypoxia-inducible factor 1α (HIF-1α), and c-myc, which resulted in blocking the activation of their downstream targets. These processes attenuated the anti-oxidation/apoptosis abilities and altered the metabolic reprogramming in SGC7901CRcells, leading to re-sensitizing these cells to cisplatin. However, overexpression of GRP75 in SGC7901 cells caused the opposite effects. A xenografts model confirmed the abovementioned results. In GC patients receiving platinum chemotherapy and a meta-analysis, a high level of GRP75 was positively associated with aggressive characteristics and poor prognosis including but not limited to gastrointestinal cancers, and was an independent predictor for overall survival. Collectively, our study indicated that GRP75 was involved in the cisplatin-resistance of GC and that GRP75 could be a potential therapeutic target for restoring the drug response in platinum-resistance cells and a useful additive prognostic tool in guiding clinical management of GC patients.


  • Open Access

    Accuracy of Multidetector Computed Tomography for N Staging of Gastric Cancer in Eastern Asia: A Meta-analysis and Systematic Review

    by Lei Xu, Xiang Gao, Jianping Zhang

    Background:Eastern Asia is a region with a high incidence of gastric cancer (GC), and the detection rate of early gastric cancer (EGC) has been rising in recent decades.2With the development of endoscopic submucosal dissection (ESD) and the scope of its indications gradually expanded,the treatment for EGC is becoming a hot topic, which involves accurate preoperative evaluation.3The purpose of this study was to assess overall accuracy of multidetector computed tomography (MDCT) in N staging of GC in Eastern Asia.4Methods: A comprehensive search was conducted to collect all relevant published studies about MDCT in assessing N staging of GC in Eastern Asia, within the PubMed, Cochrane library and Web of science databases from January 01, 2002 to April 01, 2020.5 The raw data from the included studies calculated the pooled sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for evaluating the performance of MDCT.6 The studies were grouped according to different criteria to assess the effect of possible factors on the sensitivity of MDCT.7Results: fourteen studies (5119 patients) were included in this analysis.8 In Eastern Asia, MDCT had a pooled accuracy of 67% (95% confidence interval [CI] 0.62-0.72, I = 90.1%) for N staging. By subgroup analysis, reference diameter of lymph node metastasis (LNM) and degree of tumor invasion (DTI) were correlated with the sensitivity of N staging.9 And the pooled sensitivity for N+ of EGC was relatively low.10Conclusions: In Eastern Asia, as the influence of reference diameter of LNM and DTI, the sensitivity of MDCT in N staging of GC was insufficient.11 This may lead to incorrect preoperative staging, so that patients with GC may be over treated or inadequate lymph node (LN)dissection.12 The hierarchical assessment strategy may significantly improve the sensitivity for N+ of EGC to make appropriate methods of treatment.13

  • Open Access

    Identification of a novel pathogenic MLH1 mutation and recommended genetic screening strategy: An investigation of three Chinese Lynch syndrome pedigrees

    by Fan Li, Yunwei Xia, Guoguang Wang, Chaoyang Tang, Tian Zhan, Jian Shen, Jianping Zhang

    Background: Lynch syndrome (LS) is an autosomal‐dominant disorder that increases the risk of many cancers. The genetic basis of LS is germline mutations in DNA mismatch repair genes.Methods: We performed next‐generation sequencing on blood cells obtained from the members of three unrelated LS pedigrees. Immunohistochemistry staining was performed to analyze protein expression.Results: Multigene panel screening revealed three mutL homolog 1 (MLH1) pathogenic mutations (c.199G>A, c.790 + 1G>A, and c.1557_1558 + 8delGGGTACGTAA, unreported) confirmed by Sanger sequencing. Immunohistochemistry showed a loss of MLH1 protein expression. We also confirmed that the unreported mutant allele was inherited for at least three generations.Conclusion: These results provide new insights into the molecular mechanisms underlying the pathogenicity of MLH1 mutations and reaffirm the importance of genetic screening for the early diagnosis of LS.


  • Open Access

    Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma

    by Liangsong Zhu, Rong Ding, Jianping Zhang, Jin Zhang, Zongming Lin

    This research provides the first evidence of CDK5 in ccRCC prognosis and correlation with different p21 expression in overall survival (OS) analysis. The data from both of The Cancer Genome Atlas (TCGA) and Gene Expression of Normal and Tumor Tissue (GENT) were analyzed for determining the expression of CDK5 in kidney cancer. Tissue microarray that made by using 150 ccRCC samples was used in immunohistochemistry (IHC) analysis. A validation of OS cohort was extracted from Oncomine database. The CDK5 expression was significantly lower in cancer tissue compared with normal in TCGA (p < 0.0001), GENT database also showed a relative low expression in kidney cancer. Among 150 ccRCC patients, low CDK5 was detected in 83 cases (55.3%), low p21 in 97 cases (64.7%). CDK5 was associated with the advanced TNM stage (p = 0.042), and Fuhrman grade (p = 0.035). Patients with lower CDK5 might be more likely to be aggressive status. According to the combination analysis of CDK5 and p21, patients in CDK5 low/p21 low group showed poorer survival rate, and no significant survival difference was observed in other groups. In the Cox multivariate analysis, the co-expression of CDK5 low/p21 low was identified as an independent prognostic factor in ccRCC patients. Together, our findings provided the first evidence that CDK5 was acting as a promising biomarker in ccRCC patients, and co-expression of CDK5 and p21 is an independent prognostic for overall survival. IHC analysis of CDK5 and p21 on cancer tissues after surgery may help to evaluate and predict the outcome of ccRCC patients.


  • Open Access

    Modularized laparoscopic regional en bloc mesogastrium excision (rEME) based on membrane anatomy for distal gastric cancer

    by Jian Shen, Xiaogang Dong, Zhu Liu, Guoguang Wang, Jing Yang, Fei Zhou, Ming Lu, Xiang Ma, Yuan Li, Chaoyang Tang, et al.

    The purpose of the study was to evaluate the safety and feasibility of a new surgical procedure named modularized laparoscopic regional En bloc mesogastrium excision (rEME) based on the membrane anatomy in distal laparoscopic radical gastrectomy for gastric cancer.


  • The Attenuation of 14-3-3ζ is Involved in the Caffeic Acid-Blocked Lipopolysaccharide-Stimulated Inflammatory Response in RAW264.7 Macrophages

    by Ming Lu, Yi Dai, Miao Xu, Chi Zhang, Yuhong Ma, Ping Gao, Mengying Teng, Kailin Jiao, Guangming Huang, Jianping Zhang, et al.

    Inflammation plays important roles in the initiation and progress of many diseases. Caffeic acid (CaA) is a naturally occurring hydroxycinnamic acid derivative, which shows hypotoxicity and diverse biological functions, including anti-inflammation. The molecular mechanisms involved in the CaA-inhibited inflammatory response are very complex; generally, the down-regulated phosphorylation of such important transcriptional factors, for example, nuclear factor κB (NF-κB) and signal transducers and activators of transcription-3 (STAT-3), plays an important role. Here, we found that in RAW264.7 macrophage cells, CaA blocked lipopolysaccharide (LPS)-stimulated inflammatory response by attenuating the expression of 14-3-3ζ (a phosphorylated protein regulator). Briefly, the increased expression of 14-3-3ζ was involved in the LPS-induced inflammatory response. CaA blocked the LPS-elevated 14-3-3ζ via attenuating the LPS-induced tumor necrosis factor-α (TNF-α) secretion and via enhancing the 14-3-3ζ ubiquitination. These processes inhibited the LPS-induced activation (phosphorylation) of NF-κB and STAT-3, in turn blocked the transcriptional activation of inducible NO synthase (iNOS), interleukin-6 (IL-6), and TNF-α, and finally attenuated the productions of nitric oxide (NO), IL-6, and TNF-α. By understanding a novel mechanism whereby CaA inhibited the 14-3-3ζ, our study expanded the understanding of the molecular mechanisms involved in the anti-inflammation potential induced by CaA.


  • 14-3-3η is a novel growth-promoting and angiogenic factor in hepatocellular carcinoma

    by Jian Shen, Fei Jiang, Ye Yang, Guangming Huang, Fuxing Pu, Qinqiang Liu, Lijun Chen, Liang Ju, Ming Lu, Fei Zhou, et al.


  • Open Access

    Inhibition of the Cancer Stem Cells-Like Properties by Arsenic Trioxide, Involved in the Attenuation of Endogenous Transforming Growth Factor Beta Signal

    by Yuan Li, Fei Jiang, Qinqiang Liu, Jian Shen, Xingxing Wang, Zhong Li, Jianping Zhang, Xiang Lu

    The elevation of cancer stem cells (CSCs)-like properties is involved in the initiation and progression of various human cancers. Current standard practices for treatment of cancers are less than satisfactory because of CSCs-mediated recurrence. For this reason, targeting the CSCs or the cancer cells with CSCs-like properties has become the new approach for the cancer treatments. In addition to treating leukemia, arsenic trioxide (As2O3) also suppresses other solid tumors. However, the roles of As2O3 in the regulation of CSCs-like properties remain largely uninvestigated. Here by using sphere formation assay, luciferase reporter assay, and some other molecular biology approaches, we found that As2O3 attenuated the CSCs-like properties in human hepatocellular carcinoma (HCC). Briefly, in HCC cells and mice xenograft models, As2O3 improved the expression of miR-491 by DNA-demethylation. MiR-491, which targeted the SMAD3-3′-UTR, decreased the expressions of SMAD3, and inhibited the CSCs-like properties in HCC cells. Knockdown of either miR-491 or SMAD3 attenuated the As2O3-induced inhibition of endogenous transforming growth factor beta signal and the CSCs-like properties. Further, in HCC patients, miR-491 is inversely correlated with the expressions of SMAD3, CD133, and the metastasis/recurrence outcome. By understanding a novel mechanism whereby As2O3 inhibits the CSCs-like properties in HCC, our study would help in the design of future strategies of developing As2O3 as a potential HCC chemopreventive agent when used alone or in combination with other current drugs.